27929135|t|Early life vaccination: Generation of adult - quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors
27929135|a|Intracellular pathogens represent a serious threat during early life. Importantly, even though the immune system of newborns may be characterized as developmentally immature, with a propensity to develop Th2 immunity, significant CD8+ T-cell responses may still be elicited in the context of optimal priming. Replication deficient adenoviral vectors have been demonstrated to induce potent CD8+ T-cell response in mice, primates and humans. The aim of the present study was therefore to assess whether replication-deficient adenovectors could overcome the risk of overwhelming antigen stimulation during the first period of life and provide a pertinent alternative in infant vaccinology. To address this, infant mice were vaccinated with three different adenoviral vectors and the CD8+ T-cell response after early life vaccination was explored. We assessed the frequency, polyfunctionality and in vivo cytotoxicity of the elicited memory CD8+ T cells, as well as the potential of these cells to respond to secondary infections and confer protection. We further tested the impact of maternal immunity against our replication-deficient adenoviral vector during early life vaccination. Overall, our results indicate that memory CD8+ T cells induced by adenoviral vectors in infant mice are of good quality and match those elicited in the adult host.
27929135	11	22	vaccination	T058	UMLS:C0042196
27929135	54	60	memory	T017	UMLS:C0682639
27929135	61	73	CD8+ T cells	T017	UMLS:C0242629
27929135	77	83	infant	T204	UMLS:C0920362
27929135	84	88	mice	T204	UMLS:C0025929
27929135	95	110	non-replicating	T038	UMLS:C1511692
27929135	111	129	adenoviral vectors	T103	UMLS:C1510800
27929135	130	143	Intracellular	T082	UMLS:C0178719
27929135	229	242	immune system	T022	UMLS:C0020962
27929135	279	294	developmentally	T038	UMLS:C0243107
27929135	334	337	Th2	T017	UMLS:C0242633
27929135	338	346	immunity	T038	UMLS:C0020964
27929135	360	371	CD8+ T-cell	T017	UMLS:C0242629
27929135	372	381	responses	T038	UMLS:C1318468
27929135	439	460	Replication deficient	T038	UMLS:C1511692
27929135	461	479	adenoviral vectors	T103	UMLS:C1510800
27929135	520	531	CD8+ T-cell	T017	UMLS:C0242629
27929135	532	540	response	T038	UMLS:C1318468
27929135	544	548	mice	T204	UMLS:C0026809
27929135	550	558	primates	T204	UMLS:C0033147
27929135	563	569	humans	T204	UMLS:C0086418
27929135	632	653	replication-deficient	T038	UMLS:C1511692
27929135	654	666	adenovectors	T103	UMLS:C1510800
27929135	707	726	antigen stimulation	T038	UMLS:C2250751
27929135	805	816	vaccinology	T058	UMLS:C0042196
27929135	835	841	infant	T204	UMLS:C0920362
27929135	842	846	mice	T204	UMLS:C0025929
27929135	852	862	vaccinated	T033	UMLS:C1519885
27929135	884	902	adenoviral vectors	T103	UMLS:C1510800
27929135	911	922	CD8+ T-cell	T017	UMLS:C0242629
27929135	923	931	response	T038	UMLS:C1318468
27929135	949	960	vaccination	T058	UMLS:C0042196
27929135	1032	1044	cytotoxicity	T038	UMLS:C0596402
27929135	1061	1067	memory	T017	UMLS:C0682639
27929135	1068	1080	CD8+ T cells	T017	UMLS:C0242629
27929135	1116	1121	cells	T017	UMLS:C0242629
27929135	1136	1156	secondary infections	T038	UMLS:C0442886
27929135	1168	1178	protection	T058	UMLS:C0150259
27929135	1212	1220	maternal	T033	UMLS:C1858460
27929135	1221	1229	immunity	T038	UMLS:C0020964
27929135	1242	1263	replication-deficient	T038	UMLS:C1511692
27929135	1264	1281	adenoviral vector	T103	UMLS:C1510800
27929135	1300	1311	vaccination	T058	UMLS:C0042196
27929135	1348	1354	memory	T017	UMLS:C0682639
27929135	1355	1367	CD8+ T cells	T017	UMLS:C0242629
27929135	1379	1397	adenoviral vectors	T103	UMLS:C1510800
27929135	1401	1407	infant	T204	UMLS:C0920362
27929135	1408	1412	mice	T204	UMLS:C0025929